Alzheimer’s blood test to be used in memory-loss prevention trial
By
Alicia Lasek
Nov 12, 2021
The PrecivityAD blood test will lower barriers to participation in a new clinical trial that aims to prevent the symptoms of Alzheimer’s disease, researchers say.
Healthcare workers first in line for newly approved at-home coronavirus test
By
Alicia Lasek
Apr 21, 2020
Care providers are asked to complete a short eligibility assessment before ordering the FDA-authorized test kit. Self-swabs are mailed back for testing.
Clinical briefs for Monday, June 5
By
Alicia Lasek
Jun 05, 2023
Memory support neighborhood takes ‘dignified approach’ to dementia care … Bias in test of lung function leaves up to 40% of Black males undiagnosed … FDA revokes EUA for J&J’s COVID vaccine...
COVID-19 may be a new risk factor for chronic pain, national study finds
By
Alicia Lasek
Jun 30, 2023
Fully 26% of study participants with moderate to severe COVID-19 symptoms reported frequent pain, researchers report.
FDA advisers object to Alzheimer’s drug aducanumab ahead of final decision
By
Alicia Lasek
Apr 05, 2021
The experimental Alzheimer’s drug aducanumab is not ready for federal approval in June, advisers to the Food and Drug Administration say in a new JAMA editorial.
After 20 years on the market, AbbVie’s dry-eye drug Restasis to be available as generic
By
Alicia Lasek
Feb 03, 2022
Dry eyes affect nearly 19% percent of adults aged 75 years and older, according to data from a national survey.
Older adults who have received J&J need not be concerned: expert
By
Amy Novotney
Apr 20, 2021
Joshua Sharfstein, M.D., vice dean for public health practice and community engagement at Johns Hopkins University, has a message for older adults who have received the Johnson & Johnson COVID-19 vaccine:...
Medicare C-SNP enrollment improves kidney disease outcomes: study
By
Alicia Lasek
Nov 03, 2020
Adults with end-stage renal disease appear to have lower rates of hospitalization and mortality when they enroll in Medicare’s Chronic Condition Special Needs Plans, a new investigation has found.
Feds struggle to provide COVID-19 tally for nursing homes: report
By
Alicia Lasek
May 09, 2020
Weeks after CMS announced it would begin tracking outbreaks and deaths in the nation’s eldercare facilities, there are no solid numbers available, say investigators.
25 percent of COVID patients have post-acute symptoms; Report highlights emerging care needs
By
Alicia Lasek
Jun 18, 2021
A analysis based on nearly two million private U.S. healthcare claims has identified the most common post-COVID conditions with a focus on age, gender, mental health conditions and mortality. Even 19%...